Potentiation of Antibacterial Activity of the MB-1 Siderophore-Monobactam Conjugate Using an Efflux Pump Inhibitor

Por Tomaras, Andrew P., Crandon, Jared L., McPherson, Craig J., Nicolau, David P.
Publicado no Antimicrob Agents Chemother (2015)

Adaptation-Based Resistance to Siderophore-Conjugated Antibacterial Agents by Pseudomonas aeruginosa

Por Tomaras, Andrew P., Crandon, Jared L., McPherson, Craig J., Banevicius, Mary Anne, Finegan, Steven M., Irvine, Rebecca L., Brown, Matthew F., O'Donnell, John P., Nicolau, David P.
Publicado em 2013

Clinically Relevant Gram-Negative Resistance Mechanisms Have No Effect on the Efficacy of MC-1, a Novel Siderophore-Conjugated Monocarbam

Por McPherson, Craig J., Aschenbrenner, Lisa M., Lacey, Brian M., Fahnoe, Kelly C., Lemmon, Margaret M., Finegan, Steven M., Tadakamalla, Baswanth, O'Donnell, John P., Mueller, John P., Tomaras, Andrew P.
Publicado em 2012

LpxC Inhibitors as New Antibacterial Agents and Tools for Studying Regulation of Lipid A Biosynthesis in Gram-Negative Pathogens

Por Tomaras, Andrew P., McPherson, Craig J., Kuhn, Michael, Carifa, Arlene, Mullins, Lisa, George, David, Desbonnet, Charlene, Eidem, Tess M., Montgomery, Justin I., Brown, Matthew F., Reilly, Usa, Miller, Alita A., O’Donnell, John P.
Publicado em 2014